Diseases
One of our primary goals at NeuroCure is to see the insights of basic science translated into clinical application. Through an integrative framework, we support the facilitation and development of cutting-edge therapies and new diagnostic approaches and technologies. By dovetailing outstanding basic and clinical research with expertise in conducting clinical studies, NeuroCure endeavors to find and improve treatments for a wide range of neurological diseases such as stroke, Alzheimer's disease and dementia, neuroimmunological diseases, neurodevelopmental disorders. and psychiatric disorders like autism, depression, schizophrenia, and addiction.
The Neuroscience (initially NeuroCure) Clinical Research Center (NCRC) was founded in 2008 to provide patients with the fastest possible access to new therapeutic and diagnostic options.
Currently, a specialized NCRC team is being established within the Clinical Trial Office of Charité (CTO). In the long term, this team will focus on neuroscientific and psychiatric studies, particularly in the areas of monitoring, REDCap data management, and regulatory affairs. You can contact the team via projects-cto@charite.de.
An overview of current studies at Charité can be found here: